Cindy Tahl - 04 Aug 2026 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Reporting relationship: Chief Legal and Compliance Officer
Issuer ticker: FATE
Reported as of: 04 Aug 2026
Net transaction value: -$95,405
SEC form: 4
Accepted by SEC: 05 Aug 2026, 16:03:45 UTC
Prior SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Cindy Tahl

Key filing fact

Cindy Tahl filed Form 4 for FATE THERAPEUTICS INC (FATE) on 05 Aug 2026.

Key facts

This page summarizes Cindy Tahl's Form 4 filing for FATE THERAPEUTICS INC (FATE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2026, 16:03.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: -$95,405.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001655472 Primary reporting owner

TAHL CINDY

Relationship: Chief Legal and Compliance Officer
Address: C/O FATE THERAPEUTICS, INC., 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO
Signature: /s/ Cindy Tahl
Signature date: 05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FATE transaction

Common Stock

Sale

Transaction value: $95,405
Shares: -38,800
Change %: -6.2%
Price: $2.46
Shares after: 589,355
Date: 04 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 75,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell-to-cover" transactions and were not made at the discretion of the Reporting Person.

Footnote F2

Represents the weighted average sale price of the shares sold ranging from $2.415 to $2.540 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

SEC remarks

Chief Legal and Compliance Officer